Education
About Us
Working with TipRanks
Follow Us
NAVCO Pharmaceuticals Inc (TSE:NAV)
:NAV
NAV Stock Chart & Stats
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.07
Previous CloseN/A
VolumeN/A
Average Volume (3M)13.47K
Market Cap
C$254.03K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)122.08K
Price to Earnings (P/E)0.6
Beta0.51
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding50,805,977
10 Day Avg. Volume300
30 Day Avg. Volume13,475
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NAVCO Pharmaceuticals Inc News
PremiumCompany Announcements
Navco Pharma Launches Health Canada-Approved Skin Cream
PremiumCompany Announcements
NAVCO Pharmaceuticals Bags Global Trademark
PremiumCompany Announcements
NAVCO’s Nanosilver Spray Wins Health Canada Approval
PremiumCompany Announcements
NAVCO Pharmaceuticals Approves New Share PlanPremiumCompany Announcements
Navco Pharma Launches Innovative Antimicrobial Line
PremiumCompany Announcements
NAVCO Pharmaceuticals Boosts Investor OutreachNAV FAQ
What was NAVCO Pharmaceuticals Inc’s price range in the past 12 months?
NAVCO Pharmaceuticals Inc lowest stock price was <C$0.01 and its highest was C$0.07 in the past 12 months.
What is NAVCO Pharmaceuticals Inc’s market cap?
NAVCO Pharmaceuticals Inc’s market cap is C$254.03K.
When is NAVCO Pharmaceuticals Inc’s upcoming earnings report date?
NAVCO Pharmaceuticals Inc’s upcoming earnings report date is Aug 28, 2025 which is in 78 days.
How were NAVCO Pharmaceuticals Inc’s earnings last quarter?
NAVCO Pharmaceuticals Inc released its earnings results on May 29, 2025. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.
Is NAVCO Pharmaceuticals Inc overvalued?
According to Wall Street analysts NAVCO Pharmaceuticals Inc’s price is currently Overvalued.
Does NAVCO Pharmaceuticals Inc pay dividends?
NAVCO Pharmaceuticals Inc does not currently pay dividends.
What is NAVCO Pharmaceuticals Inc’s EPS estimate?
NAVCO Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NAVCO Pharmaceuticals Inc have?
NAVCO Pharmaceuticals Inc has 50,805,977 shares outstanding.
What happened to NAVCO Pharmaceuticals Inc’s price movement after its last earnings report?
NAVCO Pharmaceuticals Inc reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -25%.
Which hedge fund is a major shareholder of NAVCO Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in TSE:NAV
Company Description
NAVCO Pharmaceuticals Inc
BMGB Capital Corp is a capital pool company.
Technical Analysis
Genix Pharmaceuticals
―
Love Pharma Inc
―
Mydecine Innovations Group
―
Luff Enterprises
―
Lumiera Health Inc
―